Industry News
By Studying Animal Health, Researchers Find Improved Ways For Developing, Testing Cancer Therapies
Aug 17, 2012
A group of Kansas State University researchers has made valuable findings in the search for cancer's cure. While researching ways to improve animal health, the scientists -- Raymond "Bob" Rowland, a virologist and professor of diagnostic medicine and pathobiology, and Deryl Troyer, professor of anatomy and physiology -- have made two important discoveries that can also improve human health... Read More
Two Approaches To Understanding The Basic Mechanics Of Cancer
Aug 17, 2012
The genomic tumult within tumor cells has provided scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard with clues to an entirely new class of genes that may serve as an Achilles' heel for many forms of cancer. As reported in the Aug... Read More
Simulated Blood Flow Device Provides Evidence Of How Bloodstream Infections Begin
Aug 17, 2012
New research may help explain why hundreds of thousands of Americans a year get sick - and tens of thousands die - after bacteria get into their blood. It also suggests why some of those bloodstream infections resist treatment with even the most powerful antibiotics... Read More
Simulated Blood Flow Device Provides Evidence Of How Bloodstream Infections Begin
Aug 17, 2012
New research may help explain why hundreds of thousands of Americans a year get sick - and tens of thousands die - after bacteria get into their blood. It also suggests why some of those bloodstream infections resist treatment with even the most powerful antibiotics... Read More
Combining BRAF Inhibitor And Immunotherapy Increases Antitumor Activity In Metastatic Melanoma
Aug 17, 2012
BRAF Inhibitor Zelboraf Boosts Effectiveness of Immunotherapy in Mouse ModelCombining the recently approved BRAF inhibitor, Zelboraf with an engineered T cell immunotherapy to treat metastatic melanoma significantly increased tumor responses and survival in an animal model, researchers at UCLA's Jonsson Comprehensive Cancer Center have shown... Read More
Combining BRAF Inhibitor And Immunotherapy Increases Antitumor Activity In Metastatic Melanoma
Aug 17, 2012
BRAF Inhibitor Zelboraf Boosts Effectiveness of Immunotherapy in Mouse ModelCombining the recently approved BRAF inhibitor, Zelboraf with an engineered T cell immunotherapy to treat metastatic melanoma significantly increased tumor responses and survival in an animal model, researchers at UCLA's Jonsson Comprehensive Cancer Center have shown... Read More
Coordinated Protein Breakdown And Synthesis: A Key To Healthy Growth Of Cells
Aug 17, 2012
Discovery has implications for cancer and diabetes research The cells in our bodies are involved in a continuous process of breakdown and re-growth that is essential to life itself. During a process that can be likened to self-cannibalism, the proteins within the cells are broken down into their component amino acids, which then act as the building blocks for the growth and renewal of cells... Read More
Coordinated Protein Breakdown And Synthesis: A Key To Healthy Growth Of Cells
Aug 17, 2012
Discovery has implications for cancer and diabetes research The cells in our bodies are involved in a continuous process of breakdown and re-growth that is essential to life itself. During a process that can be likened to self-cannibalism, the proteins within the cells are broken down into their component amino acids, which then act as the building blocks for the growth and renewal of cells... Read More
Passenger Deletions That Deactivate Essential Genes Provide New Opportunity To Strike Cancer
Aug 17, 2012
Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vulnerabilities and new avenues for attack... Read More
Passenger Deletions That Deactivate Essential Genes Provide New Opportunity To Strike Cancer
Aug 17, 2012
Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vulnerabilities and new avenues for attack... Read More
Previous Page Next Page